TABLE 2.
Clinical information on individual preeclamptic patients showing the gestational age, maternal age at delivery, week of preeclampsia diagnosis, sFlt‐1/PIGF ratio, other pathologies, treatment, and additional relevant information. PIGF:Placental growth factor
| Age of gestation (weeks + days) | Maternal age (years) | Preeclampsiadiagnosis (weeks) | sFlt‐1/PIGF ratio | Other pathologies | Treatments | Other | |
|---|---|---|---|---|---|---|---|
| 1 | 36 + 1 | 42 | 36 | 280 | – | Betamethasone Nifedipine | Assisted reproduction techniques |
| 2 | 32 + 1 | 32 | 31 | 531 | – | BetamethasoneNifedipine MgSO4 | Foetal growth restriction |
| 3 | 39 + 2 | 22 | 36 | 42 | – | – | – |
| 4 | 36 + 6 | 39 | 35 | – | Chronic hypertension, systemic lupus erythematosus | Methyldopa, Nifedipine, Hydroxychloroquine, Aspirin, Low Molecular Weight Heparin | – |
| 5 | 38 + 2 | 28 | 36 | – | Type 2 diabetes | Metformin, Insulin | – |
| 6 | 36 + 1 | 35 | 36 | – | – | Labetalol, Nifedipine | Foetal growth restriction |
| 7 | 36 + 2 | 33 | 33 | – | – | Labetalol, Nifedipine, Metformin, Insulin | – |